Hello, I did a Natural Transformation lab and have these questions to answer but don't really understand how all the processes difinetively work. If someone could explain this it would be greatly appreciated. Thank you Explain what happened in each quadrant of the TSA and DMA plates. Seven of these quadrants represent controls for this experiment – you should explain why each control was done, whether or not you would expect growth to appear in that quadrant and why, and what result you saw with your experiment (if you did not get the result that you anticipated, explain why not). Acinetobacter are common soil organisms. What do the results of this experiment tell you about potential problems that may be encountered with release of genetically modified organisms? (e.g. crops engineered for pest resistance)

Hello, I did a Natural Transformation lab and have these questions to answer but don't really understand how all the processes difinetively work. If someone could explain this it would be greatly appreciated. Thank you Explain what happened in each quadrant of the TSA and DMA plates. Seven of these quadrants represent controls for this experiment – you should explain why each control was done, whether or not you would expect growth to appear in that quadrant and why, and what result you saw with your experiment (if you did not get the result that you anticipated, explain why not). Acinetobacter are common soil organisms. What do the results of this experiment tell you about potential problems that may be encountered with release of genetically modified organisms? (e.g. crops engineered for pest resistance)

Human Heredity: Principles and Issues (MindTap Course List)

11th Edition

ISBN:9781305251052

Author:Michael Cummings

Publisher:Michael Cummings

Chapter15: Genomes And Genomics

Section: Chapter Questions

Problem 14QP

See similar textbooks

Similar questions

7) I have identified a new bacterial species that I can culture in the lab. These bacteria have a unique flagellum (tail used for swimming). I would like to determine if this species has any novel genes involved in flagella development or flagella movement. What type of genetic screen would you perform and describe how you would carry out the genetic screen to identify genes involved in flagella development or movement. Be sure to include the phenotype(s) you would be looking for in your screen.
A few companies in China and South Korea provide theservice of cloning dogs, using cells from their clients’ petsto provide nuclei in procedures like that in Figure 20.17.Should their clients expect the clone to look identical totheir original pet? Why or why not? What ethical questions does this bring up?
Cap, EA1, and Sap are all genes/proteins of interest in this study. For each gene, what gene product is encoded and where is the gene (the literal DNA sequence) located physically in the cell? I need help fimiding this in the artticle and answer as short as possible https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106848/
1. These questions will utilize yeast analysis and provide you with mock experimental data for the phenotypic analysis of yeast growth to infer genotypes. The following symbols indicate growth or no growth on medium lacking particular components (examples in 1A are medium lacking methionine "-MET" and medium lacking tryptophan "-TRP". Growth is indicated by a filled, black circle. No growth on a particular medium is indicated by an unfilled circle. In cases where we look viability of spores, we would use absence of a circle to indicate that a spore did not grow at all (for example, it inherited a lethal mutation). Growth No growth 1A. You have two haploid strains (Haploid of opposite mating types. Their genotypes and phenotypes are shown below. +MET - TRP - MET +TRP Haploid 1 MATA: MET2 trp3 Haploid 2 MATalpha: met2 TRP3 You cross each strain to a WT yeast and observe the following: Haploid 1 x WT= Growth on all three media shown above. Haploid 2 x WT= Growth on all three media shown…
STEP BY STEP Exaplanation would be appreciated so I can understand for upcomming exam. In humans, the COL1A1 locus codes for a collagen protein found in bone. A recessive COLA1 allele believed to reduce bone density and increase risk of fractures differs from the wild type allele by the presence a GT in the first intron of the gene. This mutation can be easily screened by PCR, using COL1A1-specific primers followed restriction enzyme digest of the product with MscI. The normal allele is denoted as G and the recessive allele as T. A recent study of 894 women found that 570 were GG, 291 were GT and 33 were TT. (Assume for this exercise that these values reflect both male and female values for the sampled population. What are the frequencies of each allele? What are the frequencies of each genotype? c. Is this locus in Hardy-Weinberg equilibrium? Use the table below to evaluate the significance of any deviation from H-W expectations.
You are using nitrosoguanidine to “revert” mutant nic-2(nicotinamide-requiring) alleles in Neurospora.You treat cells, plate them on a medium without nicotinamide, and look for prototrophic colonies. You obtainthe following results for two mutant alleles. Explainthese results at the molecular level, and indicate how youwould test your hypotheses.a. With nic-2 allele 1, you obtain no prototrophs at all.b. With nic-2 allele 2, you obtain three prototrophiccolonies A, B, and C, and you cross each separately with awild-type strain. From the cross prototroph A × wildtype, you obtain 100 progeny, all of which are prototrophic.From the cross prototroph B × wild type, you obtain100 progeny, of which 78 are prototrophic and 22 arenicotinamide requiring. From the cross prototrophC × wild type, you obtain 1000 progeny, of which 996 areprototrophic and 4 are nicotinamide requiring.
What type of experiment would you be most likely to use to demonstrate that protein X was directly phosphorylated by the M-cyclin/CDK pair a flow cytometry experiment a PCR based assay an in vitro assay a fluorescence microscopy experiment
Why is gene editing becoming a trend in modern genetic engineering? Provide a concrete example on your explanation. 2. Out of 4 presented methodologies in gene modification/editing, which do you think is the most promising in providing efficient result? Why do you say so? 3. What makes the species of Agrobacterium ideal for genetic engineering? Describe its characteristics and its role in producing transgenic plants. 4. In which of the following aspects do you think it is worthwhile to develop genetic engineering? Why or why not? a.) Agriculture and Food Industry b.) Medicine c.)Research d.) Entertainment 5. What are the possible bioethical issues that gene editing tools may encounter? 6. Do you think genetic engineers play God when they modify the genes of various organisms to enhance their existing traits? Why or why not?
Do a few cells created by therapeutic cloning of your own somatic cells constitute life? If these cells do constitute life, do they have the same rights as a human being conceived naturally? If it were possible, should someone be allowed to grow his or her own therapeutic clone into an adult?
Two genes associated with breast cancer, BRCA1 and BRCA2, were discovered in 1994 and 1995, respectively, and shortly thereafter, were patented by Myriad Genetics, a company based in Utah. Under the patents, testing for mutations in these genes could only be performed by Myriad, at costs from 300 to 3,000. Myriad also patented the process of analyzing the results of such tests, preventing anyone who obtains the sequence of their BRCA genes by other means (which itself would probably be patent infringement) from interpreting the information. The idea that genes can be patented has been a contentious issue from the beginning. Patents are not granted for products of nature, meaning that genes inside the body are not patentable, but biotech companies successfully argued that by removing a gene from the human body, purifying it, and then obtaining its DNA sequence, they created something not found in nature, and which is therefore a patentable invention. The U.S. Patent Office found the argument persuasive, but opponents argue that genes are parts of our bodies and can be identified but not invented. Biotech companies argue that without the protection offered by patents, they would have no incentive for research and development of diagnostic tests. In Europe, patents for BRCA1 and BRCA2 were revoked in 2004 because they did not meet the standards for a patent. After more than a decade of legal disputes, the patents were partially restored in 2008 on a very restricted basis. In the United States, a lawsuit, focused on the patents for the BRCA genes, was filed in May 2009. The suit challenges the basic idea that genes are patentable. In November 2009, the judge ruled that the lawsuit can proceed, and the case is moving forward. In March 2010, a federal court invalidated Myriad Genetics patent on these genes. In August 2011, the U.S. Court of Appeals reversed the lower courts decision and ruled that gene sequences isolated from cells are not a product of nature and are therefore patentable. The case went to the U.S. Supreme Court, which ordered the appeals court to reconsider the case. The Federal Appeals Court did not change its decision, and the case once again, went to the U.S. Supreme Court. A unanimous decision in June 2013 invalidated Myriads patents on the basis that isolating a gene from nature does not make it patentable. This is a landmark decision on gene patenting with widespread ramifications for the biotechnoloogy industry. Will this decision reduce the incentives for companies to invest in new diagnostic tests that would be used by cancer victims or those with serious genetic disorders?
As you are performing this protocol, you realize that the ultraviolet (UV) light does not work as expected, because of a fused bulb. You decide to look at plate #4 (NA with AMP; pGFP added to cells) under visible light to decide whether transformation was successful or not. Will viewing this plate under visible light tell you whether you were successful in transforming cells with pGFP DNA?
For the creatine kinase shuttle to be effective, the diffusion distance and the rate of ATP consumption would have to create a window in which PCr and Cr diffusion, but not ADP and ATP diffusion, would be fast enough to support the ATP-consuming activity. Which one of the following case creatine kinase shuttle would not be necessary? Select one: a. When the ATPase rate was very low O b. When the ATPase rate was to0 great O c. When the diffusion distance was too small O d. When the diffusion distance was too great O e. a & c O f. a & d O g. b & c O h. b & d